Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-04-28 ÀÏ 14:22
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 1,514°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Conference Report]
±¹³» ´ç´¢º´ ȯÀÚ 4¸í Áß 1¸í ½ÅÀå±â´É ¶³¾îÁ®
´ç´¢º´½ÅÀåÁúȯÀº ¸»±â½ÅÀåÁúȯÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀ¸·Î, ½ÉÇ÷°üÁúȯ ±×¸®°í »ç¸Á·ü Áõ°¡¿Í ¿¬°ü¼ºÀ» ³ªÅ¸³½´Ù. ¼ö ³â¿¡¼ ¼ö½Ê ³â¿¡ °ÉÃÄ ¹ß»ý...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 11:57
¶óÀÎ
[Conference Report]
Ç÷´ç, ½ÉÀ塤½ÅÀå, ÀúÇ÷´ç, üÁß »óº¸È¿°ú
º´Å»ý¸®¿Í Ç÷´ç°ÇÏÁ¦ ±è ±³¼ö´Â ¸ÕÀú 2Çü´ç´¢º´ÀÇ ´Ù¾çÇÑ º´Å»ý¸®¸¦ ¼Ò°³, º¹Àâ´Ù´ÜÇÑ ¹ßº´·çÆ®¸¦ ¸·°Å³ª °ø·«Çϱâ À§ÇÑ ´Ù...
ÀÌ»óµ· ±âÀÚ
|
2023-06-05 11:53
¶óÀÎ
[Cover Story]
Çѱ¹ÀÎ Áø·áÁöħÀ¸·Î º»
ÀÌ»óÁöÁúÇ÷Áõ¡¤°íÇ÷¾Ð Ä¡·á Æз¯´ÙÀÓÀÇ º¯È
À¯·´¡¤ºÏ¹ÌÀÇ Æз¯´ÙÀӹ̱¹Àӻ󳻺кñÇÐȸ(AACE)´Â Áö³ 2017³â ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀο¡¼ Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD) ÃÊ°í...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 17:45
¶óÀÎ
[Sub Story]
Çѱ¹ÀÎ ¸ñǥġ Á¤Çϴµ¥, ¼¾ç µ¥ÀÌÅÍ ¼ö¿ëÇÒ ¼ö¹Û¿¡ ¾ø¾ú´Ù
Çѱ¹ÀÎ LDL-C ¸ñǥġÇѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷ÁõÀÇ Ä¡·á¿¡ ÀÖ¾î LDLÄÝ·¹½ºÅ×·Ñ Á¶Àý ¸ñǥġ´Â ¾î¶² º¯È¸¦ °Þ¾î ¿ÔÀ»±î? Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈÇÐȸ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 17:39
¶óÀÎ
[Sub Story]
Á׻󵿸ưæÈÁõ¿¡¼ ½ÉÇ÷°üÁúȯ ¿¹¹æ±îÁö
½ºÅ¸Æ¾LDLÄÝ·¹½ºÅ×·Ñ »ó½Â → Á׻󵿸ưæÈÁõ ÁøÇà → ½ÉÇ÷°üÁúȯ ÀÌȯ¡¤»ç¸ÁÀÇ ¿¬°á°í¸®¸¦ ²÷´Â °ÍÀÌ ½ºÅ¸Æ¾ÀÇ ÀÓ¹«´Ù. ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 17:33
¶óÀÎ
[Interview]
¡°½ºÅ¸Æ¾ ´Üµ¶¿ä¹ý ÀÌ»óÁöÁúÇ÷Áõ °ü¸®ÀÇ ½ÃÀÛ¡±
Q. ÀÌ»óÁöÁúÇ÷Áõ °ü¸®¿¡¼ °í°µµ ½ºÅ¸Æ¾ÀÇ ¿ªÇÒÀÌ Ä¿Áö°í ÀÖ´Ù. ÀÌ¿¡ ´ëÇÑ ¹è°æÀº?¾Õ¼ ÁøÇàµÈ ¿¬±¸¿¡¼´Â LDL-C¸¦ °¨¼Ò½Ãų¼ö·Ï ½ÉÇ÷...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 16:45
¶óÀÎ
[Sub Story]
LDL-C ¸ñǥġ ÇÏÇâ°ú ½ºÅ¸Æ¾·ºñ½ºÅ¸Æ¾°è º´¿ëÀÇ »ó°ü°ü°è
¸ñǥġ ÇÏÇâÁ¶Á¤ÀÇ ÆÄÀå¸ñǥġÀÇ º¯È´Â ÇÊ¿¬ÀûÀ¸·Î ¾à¹°Ä¡·áÀÇ º¯È¿Í Á÷°áµÈ´Ù. Çа迡¼´Â ¿¬À̾î ÇÏÇâÁ¶Á¤µÇ°í ÀÖ´Â LDLÄÝ·¹½ºÅ×·Ñ ¸ñǥġ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 16:31
¶óÀÎ
[Interview]
¡°ÀþÀº ¼ºÀκÎÅÍ Àû±ØÀûÀ¸·Î LDL-C °ü¸®Çؾߡ±
Q. LDL-C °ÇÏ Àü·«ÀÇ ÇÙ½ÉÀº ¹«¾ùÀΰ¡?ÀÌ»óÁöÁúÇ÷Áõ ¹× ASCVD À§Çè °¨¼Ò¸¦ À§ÇØ °¡Àå Áß¿äÇÑ °ÍÀº ¾ó¸¶³ª ¸¹ÀÌ LDL-C¸¦ ³·...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 16:24
¶óÀÎ
[Late Breaking Studies]
½ºÅ¸Æ¾ vs ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê ±Ù°Å¿Í ÇöÁÖ¼Ò Â¤¾îº¸±â
°íÀ§Çè ȯÀÚ¿¡¼ ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê ÃÊÄ¡·á Àü·«:Pros- The lower, the betterÁß¾ÓÀÇ´ë Á¤¿µÈÆ ±³¼ö(Á߾Ӵ뱤¸íº´¿ø ...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 16:11
¶óÀÎ
[Sub Story]
ACS ȯÀÚ ÀÌ»óÁöÁúÇ÷Áõ ÃʱâÄ¡·á 2¡¤3Á¦ º´¿ëÀ¸·Î?
The Lower, The BetterLDLÄÝ·¹½ºÅ×·ÑÀ» ³·Ãß¸é ³·Ãâ¼ö·Ï ½ÉÇ÷°üÁúȯ ¿¹¹æ¿¡ ´õ µµ¿òÀÌ µÈ´Ù´Â ¡®LDL À̷С¯ÀÌ ÃÖ±Ù ´Ù½Ã...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 15:29
¶óÀÎ
[Sub Story]
¸ñÇ¥Ç÷¾Ð¡é°ú º´¿ë¿ä¹ý¡èÀÇ »ó°ü°ü°è
2022³â °íÇ÷¾Ð Áø·áÁöħ´ëÇÑ°íÇ÷¾ÐÇÐȸ´Â 2022³â »õ °íÇ÷¾Ð Áø·áÁöħ¿¡¼ ¸ñÇ¥Ç÷¾Ð¿¡ ´õ °øÀ» µéÀÌ¸ç °·ÂÇÑ Ç÷¾ÐÁ¶Àý Æз¯´ÙÀÓÀ» Àû±Ø ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 14:33
¶óÀÎ
[Interview]
LDL-C Ä¡·á Æз¯´ÙÀÓ, The Lower¡¤The Earlier
Q. ±¹³»¿Ü °¡À̵å¶óÀο¡¼ LDL-C ¸ñǥġ´Â ¾î¶»°Ô ±Ç°íµÇ°í ÀÖ³ª?Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD) º´·ÂÀÚ¿¡¼ LDLÄÝ·¹½ºÅ×·Ñ(L...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 14:32
¶óÀÎ
[Sub Story]
Çѱ¹ÀÎ °íÁß¼ºÁö¹æÇ÷Áõ Ä¡·á¿¡ ÇǺ극ÀÌÆ®¡¤¿À¸Þ°¡-3Áö¹æ»ê
Çѱ¹ÀÎ º¹ÇÕÇü ÀÌ»óÁöÁúÇ÷ÁõÇѱ¹ÀÎ ½É±Ù°æ»öÁõ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ KAMIR(Korea Acute Myocardial Infarction ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 14:24
¶óÀÎ
[Deep in Guideline]
±¹³» °íÇ÷¾Ð ¸ÂÃãÄ¡·á, Ç÷¾ÐºÐ·ùºÎÅÍ ½ÃÀÛ
¼±º°°Ë»ç2022³â Áø·áÁöħ¿¡¼´Â 20¼¼ ÀÌ»ó ¸ðµç ¼ºÀÎÀ» ´ë»óÀ¸·Î Ç¥ÁØ Ç÷¾ÐÃøÁ¤¹æ¹ýÀ» ÀÌ¿ëÇÑ °íÇ÷¾Ð ¼±º°°Ë»ç¸¦ ±Ç°íÇß´Ù. ƯÈ÷ ÀÌ ±Ç°í...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 14:20
¶óÀÎ
[Sub Story]
½ÉÇ÷°üÁúȯ ¾ø¾îµµ Ç÷¾Ð¡¤ÁöÁú µ¿½ÃÄ¡·á·Î 1Â÷¿¹¹æ ¼º°ø
HOPE-3°íÇ÷¾Ð°ú ÀÌ»óÁöÁúÇ÷ÁõÀÇ µ¿½ÃÄ¡·á, Áï Ç×°íÇ÷¾ÐÁ¦¿Í ½ºÅ¸Æ¾ º´¿ë¿ä¹ýÀÇ ½ÉÇ÷°ü ÀÓ»óÇýÅÃÀ» ¸íÈ®È÷ º¸¿©ÁØ »ç·Ê·Î´Â ¹«ÀÛÀ§¡¤´ëÁ¶±º ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 13:27
¶óÀÎ
[Sub Story]
±¹»ê ARB Á¦Á¦ ´Üµ¶¡¤º´¿ëÀÇ À¯È¿¼º¡¤¾ÈÀü¼º ÀÓ»ó±Ù°Å ¾÷µ¥ÀÌÆ®
Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý ° ±³¼ö´Â ¸ÕÀú °íÇ÷¾ÐÀÌ ½ÉÇ÷°üÁúȯ »ç¸ÁÀÇ ´ëÇ¥Àû À§ÇèÀÎÀÚ·Î ¿©ÀüÈ÷ ¸ÍÀ§¸¦ ¶³Ä¡°í ÀÖ´Â »óȲ¿¡¼ °·Â...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 11:58
¶óÀÎ
[Conference Report]
±¹»ê SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø
Çѱ¹ÀÎ ´ë»ó ´Ù¾çÇÑ ÀÓ»ó±Ù°Å °®Ãç
½ÉÇ÷°üÁúȯ ¿¹¹æÈ¿°úÀÓ ±³¼ö´Â ¸ÕÀú Çö´Ü°è¿¡¼ Àü¼¼°èÀûÀ¸·Î 2Çü´ç´¢º´ Ä¡·á¿¡ ³Î¸® ±ÇÀåµÇ°í ÀÖ´Â Ç÷´ç°ÇÏÁ¦ °è¿·Î SGLT-2¾ïÁ¦Á¦¿Í G...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 11:22
¶óÀÎ
[Interview]
À̳ªº¸±Û¸®Ç÷ÎÁø ¿¬±¸³í¹® ¸®ºä¾îµé
¡°¼¼°è ´ç´¢º´ Ä¡·á À§ÇÑ ¾àÁ¦¡¤±Ù°Å¿¡ °¨»ç¡±
Q. SGLT-2¾ïÁ¦Á¦ÀÇ ¿ªÇÒ°ú °è¿È¿°ú´Â?Áö±Ý±îÁö º¸°íµÈ ¿¬±¸¿¡ µû¸£¸é, SGLT-2¾ïÁ¦Á¦ °è¿¿¡¼ Ç÷´ç°ÇÏ È¿°ú¿¡ ´õÇØ ½ÉÀ塤½ÅÀå ...
ÀÌ»óµ· ±âÀÚ
|
2023-05-04 11:05
¶óÀÎ
[Interview]
¡°¿ì¼öÇÑ È¿°ú¿Í ¾ÈÀü¼ºÀ¸·Î ½Ã³ÊÁö ±â´ëÇÒ ¼ö ÀÖ´Â À§¿° Ä¡·áÁ¦¡±
Q. ±¹³» À§¿° À¯º´·üÀÌ ³ôÀº °ÍÀ¸·Î ³ªÅ¸³ª°í ÀÖ´Ù. ÀÓ»óÀûÀ¸·Î ÁÖ¸ñÇؾßÇÒ ºÎºÐÀº ¹«¾ùÀΰ¡?±¹³» 40°³ ±â°üÀÇ °Ç°°ËÁø¼¾Å͸¦ ¹æ¹®ÇÑ ÀÏ...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 10:58
¶óÀÎ
[Drug Review]
¿¡¼Òµà¿À¿¡½º, Á¦ÇüÅ©±â ´õ ÁÙÀÎ ¼Ó¹æÇü ¿¡½º¿À¸ÞÇÁ¶óÁ¹
PPI Àü·«ÀÇ ÇÑ°èÁ¡GERD Áõ»óÀº ÀÏ»ó»ýÈ°¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö Àֱ⠶§¹®¿¡ ºü¸¥ Áõ»ó ¿ÏÈ°¡ Ä¡·áÀÇ ¸ñÀû Áß Çϳª·Î ²ÅÈù´Ù. 1Â÷ Ä¡·á...
ÀÓ¼¼Çü ±âÀÚ
|
2023-05-04 10:47
-
ÀÌÀü
11
12
13
14
15
16
17
18
19
20
´ÙÀ½
-
¿©¹é
Sub
news
¡°Á¹·¹µå·Î³×ÀÌÆ® °ñÀý¿¹¹æ ÀÓ»ó±Ù°Å¡¤ÀûÀÀÁõ ÃÖ´Ù¡±
Q. °ñÀý¿¹¹æÀ» À§ÇÑ ¾à¹°Ä¡·á´Â ¾î¶»°Ô ±Ç°í...
¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡±
Q. ´ç´¢º´ Ä¡·á½Ã CGM ÀÓ»óÀû ¿ªÇÒÀº?ÀÓ...
¡°·Î¼ö¹Ù½ºÅ¸Æ¾ 20³â ±Ù°Å·Î ¼öÆÛ½ºÅ¸Æ¾ ¸í¼º À¯ÁöÇÒ °Í¡±
Q. ´ç´¢º´ ȯÀÚ¿¡¼ ÁöÁúÄ¡·á°¡ ÇÊ¿äÇÑ ÀÌÀ¯...
¿©¹é
¿©¹é
Back to Top